Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Depreciation and Depletion (2020 - 2025)

Bolt Biotherapeutics' Depreciation and Depletion history spans 6 years, with the latest figure at $300000.0 for Q3 2025.

  • For Q3 2025, Depreciation and Depletion fell 40.0% year-over-year to $300000.0; the TTM value through Sep 2025 reached $1.4 million, down 26.32%, while the annual FY2024 figure was $1.8 million, 5.26% down from the prior year.
  • Depreciation and Depletion for Q3 2025 was $300000.0 at Bolt Biotherapeutics, roughly flat from $300000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.8 million in Q1 2024 and bottomed at -$900000.0 in Q2 2024.
  • The 5-year median for Depreciation and Depletion is $400000.0 (2021), against an average of $400000.0.
  • The largest YoY upside for Depreciation and Depletion was 260.0% in 2024 against a maximum downside of 325.0% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $400000.0 in 2021, then increased by 25.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then decreased by 20.0% to $400000.0 in 2024, then fell by 25.0% to $300000.0 in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Depreciation and Depletion are $300000.0 (Q3 2025), $300000.0 (Q2 2025), and $400000.0 (Q1 2025).